India Veterinary Diagnostic Test Kits Market is expected to reach US$ 62.03 million by 2030

Publisher: The Insight Partners

Companion Animal Segment to Dominate India Veterinary Diagnostic Test Kits Market During 2022–2030 

According to our new research study on "India Veterinary Diagnostic Test Kits Market Size and Forecast (2020–2030), Country Share, Trend, and Growth Opportunity Analysis," the market value is expected to surge from US$ 29.13 million in 2022 to US$ 62.03 million by 2030; the market is anticipated to record a CAGR of 9.91% from 2022 to 2030. Key factors driving the India veterinary diagnostic test kits market growth include the rising prevalence of zoonotic disease, an increase in the adoption of companion animals, and a shift toward POCT testing in animals. However, the lack of skilled professionals in veterinary research and the inadequacy of veterinary diagnostics infrastructure hinder the market growth. Further, the increasing expenditure on animal well-being is expected to bring new India veterinary diagnostic test kits market trends in the coming years.

According to the World Health Organization (WHO), Zoonotic diseases are illnesses and infections that naturally spread from vertebrate animals to humans and are shared by both species. These diseases can cause infections of mild to severe levels. Major zoonotic diseases include trypanosomiasis, lumpy disease, Kyasanur forest disease (KFD), Nipah, rabies, brucellosis, toxoplasmosis, cysticercosis, echinococcosis, Japanese encephalitis (JE), plague, leptospirosis, scrub typhus, and Crimean-Congo hemorrhagic fever (CCHF). In 2020, the NCBI reported that zoonotic illnesses were on the rise in India. Further, in 2021, an NCBI study reported the brucellosis prevalence in India to be at 12%—with an average national rate of infection of 5% in cattle, 3% in buffalo, 7.9% in sheep, and 2.2% in goats. The incidence of brucellosis infection in cattle and buffalo in Punjab, India, was reported to be 9.9% and 13.4%, respectively. While the total prevalence of brucellosis in Punjab was 18.3%, its prevalence in cattle and buffalo rose to 16.4% and 20.7%, respectively.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00038951

According to an article published in the National Library of Medicine (NLM), India has the highest burden of zoonotic diseases. In 2023, the economic burden of dog-mediated rabies is estimated to be US$ 8.6 billion/year in India In addition to this, efforts are being made by the Indian government to manage zoonoses. For instance, the National Center for Disease Control has initiated the following programs:

• Integrated Disease Surveillance Programme (IDSP)
• National Programme for Containment of Anti-Microbial Resistance
• National Viral Hepatitis Surveillance Programme
• National Rabies Control Programme
• Programme for Prevention and Control of Leptospirosis

The National Center for Disease Control also focused on strengthening inter-sectoral coordination for the prevention and control of zoonotic diseases of public health importance. Thus, the increasing prevalence of zoonotic diseases fuels the demand for diagnostic test kits, which drives the India veterinary diagnostic test kits market growth.

The India veterinary diagnostic test kits market analysis is carried out by identifying and evaluating key players in the market across different regions. Zoetis, Inc., Secure Diagnostics, Thermo Fisher Scientific, Inbios India, Ubio Bitechnology Systems, Gold Standerd Diagnostics, VMRD Inc., Fujifilm, Randox Laboratories Ltd, and Idexx Laboratories are among the prominent players profiled in the India veterinary diagnostic test kits market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem.

The India veterinary diagnostic test kits market forecast can help stakeholders plan their growth strategies. In February 2023, Thermo Fisher Scientific launched Applied Biosystems TaqPath PCR kits for the diagnosis of infectious diseases such as multi-drug resistant tuberculosis, hepatitis B virus, hepatitis C virus, M. tuberculosis complex, and human immunodeficiency virus (HIV) infection. The kits are also used for genetic analysis of HLA B27. The kits are compatible with human and animal samples, such as buccal swabs, blood, and card punches. The Central Drugs Standard Control Organisation granted licensing rights to the company, and it will manufacture the kits in association with Mylab Discovery Solutions.

In December 2021, A'alda Vet India and Fujifilm India partnered to improve pet healthcare facilities. As part of the collaboration, Fujifilm India planned to offer DCC (Dogs, Cats & Companions) Animal Hospital with cutting-edge medical and screening equipment. This initiative was taken by A'alda Vet to raise the bar for veterinary treatment in India. With more individuals adopting pets, India has one of the fastest-growing pet care markets in the world. Therefore, it is more crucial than ever for people to have improved access to local pet care facilities that meet international standards.

The scope of the India veterinary diagnostic test kits market report encompasses the following segments: product, testing type, application, and end user. Based on the product, the market is bifurcated into ELISA test kit and PCR test kit. The ELISA test kit segment held a larger India veterinary diagnostic test kits market share in 2022. The PCR test kit segment is anticipated to register a higher CAGR during 2022–2030. Based on Animal Type, the India veterinary diagnostic test kits market is segmented into companion animals and livestock animal. The companion animals segment held a larger market share in 2022, and the livestock animal segment is anticipated to register a higher CAGR from 2022 to 2030.

By application, the market is differentiated into infectious diseases and non-infectious diseases. In 2022, the infectious diseases segment held a larger market share. The non-infectious diseases segment is anticipated to register a higher CAGR during 2022–2030. Based on testing type, the market is differentiated into laboratory testing and rapid testing (POC testing). The laboratory testing segment held a larger India veterinary diagnostic test kits market share in 2022. The rapid testing (POC testing) segment is anticipated to register a higher CAGR during 2022–2030. In terms of end users, the India veterinary diagnostic test kits market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities. The veterinary hospitals and clinics segment is anticipated to hold a significant market share during 2022–2030. 

Contact Us
Contact Person: Content Team 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com